The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
Intestinal microbiome in short bowel syndrome: diagnostic and therapeutic opportunities
Abstract
Purpose of review: The intestinal microbiome plays a strong, complementary role in the development and integrity of the intestinal epithelium. This biology is crucial for intestinal adaptation, particularly after the mucosal insults that lead to short bowel syndrome (SBS). The purpose of this review is to discuss relationships between the intestinal microbiota and the physiology of intestinal adaptation. Recent findings: We will address interactions between the intestinal microbiome and nutritional metabolism, factors leading to dysbiosis in SBS, and common compositional differences of the gut microbiome in SBS patients as compared to healthy controls. We will also discuss novel opportunities to expand diagnostic and therapeutic interventions in this population, by using our knowledge of the microbiome to manipulate luminal bacteria and study their resultant metabolites. As microbial therapeutics advance across so many fields of medicine, this review is timely in its advocacy for ongoing research that focuses on the SBS population. Our review will discuss 4 key areas: 1) physiology of the intestinal microbiome in SBS, 2) clinical and therapeutic insults that lead to a state of dysbiosis, 3) currently available evidence on microbiome-based approaches to SBS management, and 4) opportunities and innovations to inspire future research. Summary: The clinical implications of this review are both current, and potential. Understanding how the microbiome impacts intestinal adaptation and host physiology may enhance our understanding of why we experience such clinical variability in SBS patients’ outcomes. This review may also expand clinicians’ understanding of what ‘personalized medicine’ can mean for this patient population, and how we may someday consider our nutritional, therapeutic, and prognostic recommendations based on our patients’ host, and microbial physiology.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Dysbiosis in SBS also contributes to alterations such as impaired intestinal adaptation, worsened nutrient malabsorption, prolonged dependence on PN, increased susceptibility to sepsis, a higher risk of IFALD and an increased risk of SIBO [4,13,15].”
From Pre-, Pro-, Post- and Synbiotics in Pediatric Short Bowel Syndrome: A Narrative Review of Current Evidence (2026) · cites this paper as [13]
Citations
Cites
An obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444 · cited 1×
“These data strongly support a metabolic role of intestinal bacteria that may affect host nutrition, via the fermentation of polysaccharides, regulation of lipid storage, and other core metabolic functions [25,37].”
From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites
Koh, A., De Vadder, F., Kovatcheva-Datchary, P., & Bäckhed, F. (2016) · Cell · doi:10.1016/j.cell.2016.05.041 · Cited by 7,070 · cited 1×
“These SCFA also have important benefits to promote intestinal adaptation, including stimulating vascular flow, slowing motility, regulating sodium absorption, and promoting cellular proliferation and differentiation through interactions with enterochromaffin cells’ free fatty acid receptors [10].”
Bile salt biotransformations by human intestinal bacteria
Ridlon, J. M., Kang, D.-J., & Hylemon, P. B. (2006) · Journal of Lipid Research · doi:10.1194/jlr.r500013-jlr200 · Cited by 2,829 · cited 2×
“Boutte et al. reported observational data from SBS patients showing that those who successfully weaned off PN were enriched with Lachnospir-aceae and Clostridia cluster XIVa , which participate in bile acid metabolism [23 ,45].”
The Microbiome in Inflammatory Bowel Disease: Current Status and the Future Ahead
Kostic, A. D., Xavier, R. J., & Gevers, D. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.02.009 · Cited by 1,789 · cited 1×
“The microbiome has been implicated in the pathogenesis of several of these conditions, including NEC [5,6], Crohn’s disease [7], and”
Rezaie, A., Buresi, M., Lembo, A., Lin, H., McCallum, R., Rao, S., Schmulson, M., Valdovinos, M., Zakko, S., & Pimentel, M. (2017) · American Journal of Gastroenterology · doi:10.1038/ajg.2017.46 · Cited by 852 · cited 1×
“Further research into the role of novel urinary metabolites to help predict, or monitor intestinal adaptation are needed. gastrointestinal disorders, including SBBO [73].”
Gut bacteria that prevent growth impairments transmitted by microbiota from malnourished children
Blanton, L. V., Charbonneau, M. R., Salih, T., Barratt, M. J., Venkatesh, S., Ilkaveya, O., Subramanian, S., Manary, M. J., Trehan, I., Jorgensen, J. M., et al. (2016) · Science · doi:10.1126/science.aad3311 · Cited by 735 · cited 1×
“A 2016 study by Blanton et al. showed that the microbiota of children experiencing malnutrition can recapitulate growth hormone resistance and stunting in germ-free mice and may subsequently be reversed by transferring the microbiota of healthy children [36].”
Revicki, D. A., Wood, M., Wiklund, I., & Crawley, J. (1997) · Quality of Life Research · doi:10.1023/a:1008841022998 · Cited by 617 · cited 2×
“The authors reported a significant improvement in SBBO symptoms (based on the validated Gastrointestinal Symptom Rating Scale [60]) in 100% of patients receiving FMT [61].”
Fecal Microbiota in Premature Infants Prior to Necrotizing Enterocolitis
Mai, V., Young, C. M., Ukhanova, M., Wang, X., Sun, Y., Casella, G., Theriaque, D., Li, N., Sharma, R., Hudak, M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020647 · Cited by 504 · cited 5×
“Causes of SBS vary and may include necrotizing enterocolitis (NEC), midgut volvulus (or other vascular insults that lead to ischemia), or progressive inflammation (such as Crohn’s disease) [4].”
InfluentialAntibiotic Exposure and IBD Development Among Children: A Population-Based Cohort Study
Kronman, M. P., Zaoutis, T. E., Haynes, K., Feng, R., & Coffin, S. E. (2012) · Pediatrics · doi:10.1542/peds.2011-3886 · Cited by 445
Two cases of Lactobacillus bacteremia during probiotic treatment of short gut syndrome
Kunz, A. N., Noel, J. M., & Fairchok, M. P. (2004) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-200404000-00017 · Cited by 319
Cited by
Hilberath, J., Busch, A., Schoppmeier, U., Schmauder, K., Oberhettinger, P., Marschal, M., Slavetinsky, C. J., Sturm, E., Peter, S., & D’Alvise, P. (2025) · Journal of Parenteral and Enteral Nutrition · doi:10.1002/jpen.2808 · Cited by 5
Does Microbiome Matter in Chronic Intestinal Failure Due to Type 1 Short Bowel Syndrome in Adults?
Ossola, M., Ferrocino, I., Franciosa, I., Aimasso, U., Cravero, L., Bonciolini, A., Cardenia, V., Merlo, F. D., Anrò, M., Chiarotto, A., et al. (2024) · Nutrients · doi:10.3390/nu16142282 · Cited by 6
Sugita, K., Yano, K., Onishi, S., Tabata, Y., Iwamoto, Y., Ogata, M., Takada, L., Kedoin, C., Murakami, M., Harumatsu, T., et al. (2024) · Pediatric Surgery International · doi:10.1007/s00383-024-05776-z · Cited by 4
Ruiz, R. G., Morelli, A., Grieco, R., Cardile, S., Capriati, T., Trovato, C. M., Bolasco, G., Knafelz, D., Bracci, F., Alterio, A., et al. (2026) · Children · doi:10.3390/children13030349 · Cited by 3
“…[10,14]. https://doi.org/10.3390/children13030349 Dysbiosis in SBS also contributes to alterations such as impaired intestinal adaptation, worsened nutrient malabsorption, prolonged dependence on PN, increased susceptibility to sepsis, a higher risk of IFALD and an increased risk of SIBO [4,13,15].”
InfluentialThe Gut’s Secret Code: Bowel Microbiota as a Biomarker for Adaptation
Sochacka, J. B. , Sochacki, J., & Mik, M. (2025) · Nutrients · doi:10.3390/nu17132117 · Cited by 4
“…studies with standardized 16S rRNA sequencing methods and rigorous control of confounding factors—such as antibiotic exposure and dietary variation—in order to validate microbial biomarkers and develop evidence-based therapeutic strategies tailored to the microbiome profile of SBS patients [57].”
Metadata
- Authors
- Chowdhury, F., Hill, L., Shah, N., Popov, J., Cheveldayoff, P., & Pai, N.
- Affiliations
- McMaster University (CA)
- McGill University Health Centre (CA)
- Harvard University (US)
- McMaster Children's Hospital (CA)
- Corresponding author
- Pai, Nikhil
- Venue
- Current Opinion in Gastroenterology
- Published
- 2023-09-18
- Volume
- 39
- Issue
- 6
- Pages
- 463-471
- ISSN
- 0267-1379 (ISSN-L)
- 1531-7056
- OpenAlex
- W4387043904
- Cited by
- 11
- References
- 77
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 2
- FWCI
- 0.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Opinion in Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Nursing › Nutrition and Dietetics › Clinical Nutrition and Gastroenterology
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- short bowel syndrome, gut microbiota, intestinal adaptation, dysbiosis, gut microbiota composition, nutrient metabolism, microbial metabolites, microbiota-based therapy, personalized medicine, intestinal epithelium
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Intestinal microbiome in short bowel syndrome: diagnostic and therapeutic opportunities. https://app.cochat.ai/papers/10.1097/mog.0000000000000970
- The paper
- Chowdhury, F., Hill, L., Shah, N., Popov, J., Cheveldayoff, P., & Pai, N. (2023). Intestinal microbiome in short bowel syndrome: diagnostic and therapeutic opportunities. Current Opinion in Gastroenterology. https://doi.org/10.1097/mog.0000000000000970
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.